Passage Bio Stock (NASDAQ: PASG) stock price, news, charts, stock research, profile.
You can purchase shares of Passage Bio (NASDAQ:PASG) through any online brokerage.
Other companies in Passage Bio’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX) and OncoCyte (NASDAQ:OCX).
Passage Bio has a consensus price target of $8.00.
The stock price for Passage Bio (NASDAQ: PASG) is $0.66 last updated September 25, 2024 at 12:21 PM EDT.
There are no upcoming dividends for Passage Bio.
Passage Bio’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Passage Bio.
Passage Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.